NCT01153828View on ClinicalTrials.gov

EU PV for Retapamulin-Prescribing

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Impetigo
Interventions
DRUG

Retapamulin

Prescription for retapamulin

DRUG

Co-prescription of retapamulin and topical mupirocin

Same day prescriptions for retapamulin and topical mupirocin

DRUG

Co-prescription of retapamulin and topical fusidic acid

Same day prescription for retapamulin and fusidic acid.

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY